Table 4:

Susceptibility values among patients receiving different chelation agents

Mean (SD) /10−2 ppmP Value
DFOL1DFO+L1Exjade
PT1.82 (0.69)2.09 (0.50)1.81 (0.59)2.07 (0.85).201
GP7.64 (2.07)6.69 (3.50)5.62 (1.73)7.06 (1.06).296
CN2.37 (0.60)1.66 (0.49)1.98 (0.54)2.09 (0.80).232
DN4.95 (1.53)3.50 (1.57)4.44 (2.08)5.44 (1.55).064
SN6.87 (1.77)5.89 (1.61)6.28 (1.15)6.08 (0.86).573
RN6.01 (3.23)7.26 (1.85)6.86 (1.90)6.55 (3.68).801
CP7.38 (4.28)7.03 (3.63)7.47 (6.09)6.24 (1.75).955
  • Note:—No significant difference was found in susceptibility values between patients receiving different chelation agents.

  • DFO indicates deferoxamine; L1, deferiprone; SD, standard deviation; PT, putamen; CN, caudate nucleus; RN, red nucleus.